glp 1 dpp 4 pathway Cardiovascular effects of DPP-4 inhibition: Beyond GLP-1 Cellular Sites and Mechanisms Linking

Shelby created Primal Queen after discovering the benefits of beef organ superfoods for nutrition, balance, and energy

A resource clinicians can signpost patients towards.

World Obesity Federation, World Obesity Atlas 2023 Unsurprisingly, weight loss medications have captured innovators attention as potential solutions, however, the obesity market has a history of many false dawns, as drugs in the past failed to deliver meaningful efficacy while some had serious safety issues, e.g., Fen-Phen, which was eventually withdrawn from the market due to cardiac risks3

Clinical breakthroughs, shifting policies, and changing market dynamics are converging to redefine obesity care globally

Questions, Comments

Eli Lilly became the first healthcare or pharma company to reach a $1 trillion valuation